Abstract
Non receptor protein tyrosine kinases are targets in the treatment of a number of diseases. This review focuses on the role of Fes tyrosine kinase and on the design of inhibitors of this protein. Fes and its homologously related protein Fer are the only two members of a distinct class of non receptor tyrosine kinases and they seem to play a role in cytoskeletal rearrangements and inside-out signalling associated with receptor-ligand, cell-matrix and cell-cell interactions. The knowledge of the three dimensional structure of this protein, in fact, has informed drug design, while at the same time it has helped to shed some light on the molecular mechanism at the basis of kinase activation and functions.
Keywords: Fes kinase, non receptor tyrosine kinase, structure based drug design, protein structure, protein crystallography
Current Medicinal Chemistry
Title: Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Volume: 18 Issue: 19
Author(s): F. Condorelli, E. Stec-Martyna, J. Zaborowska, L. Felli, I. Gnemmi, M. Ponassi and C. Rosano
Affiliation:
Keywords: Fes kinase, non receptor tyrosine kinase, structure based drug design, protein structure, protein crystallography
Abstract: Non receptor protein tyrosine kinases are targets in the treatment of a number of diseases. This review focuses on the role of Fes tyrosine kinase and on the design of inhibitors of this protein. Fes and its homologously related protein Fer are the only two members of a distinct class of non receptor tyrosine kinases and they seem to play a role in cytoskeletal rearrangements and inside-out signalling associated with receptor-ligand, cell-matrix and cell-cell interactions. The knowledge of the three dimensional structure of this protein, in fact, has informed drug design, while at the same time it has helped to shed some light on the molecular mechanism at the basis of kinase activation and functions.
Export Options
About this article
Cite this article as:
Condorelli F., Stec-Martyna E., Zaborowska J., Felli L., Gnemmi I., Ponassi M. and Rosano C., Role of the Non-Receptor Tyrosine Kinase Fes in Cancer, Current Medicinal Chemistry 2011; 18 (19) . https://dx.doi.org/10.2174/092986711796150522
DOI https://dx.doi.org/10.2174/092986711796150522 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Paving Roads for New Drugs in Oncology
Recent Patents on Anti-Cancer Drug Discovery Epigenetics in Vascular Disease – Therapeutic Potential of New Agents
Current Vascular Pharmacology Structural and Functional Role of Gly281 in L-asparaginase from Erwinia carotovora
Protein & Peptide Letters Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats
CNS & Neurological Disorders - Drug Targets Natural Products Based Anticancer Agents
Mini-Reviews in Organic Chemistry Targeting mTOR Pathways in Human Malignancies
Current Pharmaceutical Design A New Approach for β-cyclodextrin Conjugated Drug Delivery System in Cancer Therapy
Current Drug Delivery Extracellular Production of the Oncolytic Enzyme, L-Asparaginase, by Newly Isolated Streptomyces sp. Strain NEAE-95 as Potential Microbial Cell Factories: Optimization of Culture Conditions Using Response Surface Methodology
Current Pharmaceutical Biotechnology Ras Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target
Mini-Reviews in Medicinal Chemistry Immune Checkpoint Inhibitors in AML-A New Frontier
Current Cancer Drug Targets Self-Assembling Peptides: Potential Role in Tumor Targeting
Current Pharmaceutical Biotechnology Mitochondrial DNA Mutations in Cancer: A Review
Current Topics in Medicinal Chemistry MicroRNAs as Main Players in the Pathogenesis of Chronic Lymphocytic Leukemia
MicroRNA Strategies for the Design of Potent and Selective Kinase Inhibitors
Current Pharmaceutical Design Poly(ADP-ribose)polymerase Inhibition - Where Now?
Current Medicinal Chemistry n-3 Polyunsaturated Fatty Acids and the Prevention of Colorectal Cancer: Molecular Mechanisms Involved
Current Medicinal Chemistry Proresolution Mediators and Receptors: Novel Drug Targets for Enhancing Pharmacological Armamentarium against Periodontal Inflammation
Infectious Disorders - Drug Targets Herpes Simplex Virus Vectors for the Nervous System
Current Gene Therapy HSP90 Inhibitors: Multi-Targeted Antitumor Effects and Novel Combinatorial Therapeutic Approaches in Cancer Therapy
Current Medicinal Chemistry Epigenetic Modifications as Therapeutic Targets
Current Drug Targets